Association of urinary transforming growth factor-β1 with the ureteropelvic junction obstruction

Area of Science:

• Pediatric Nephrology
• Urology
• Biomarker Discovery

Background:

• Ureteropelvic junction obstruction (UPJO) is a common congenital anomaly in children.
• Accurate diagnosis and monitoring of UPJO are crucial for preserving renal function.
• Identifying reliable biomarkers for UPJO is an ongoing area of research.

Purpose of the Study:

• To compare urinary transforming growth factor-beta 1 (TGF-β1) levels in children diagnosed with UPJO versus healthy controls.
• To investigate the correlation between urinary TGF-β1 levels and the severity of UPJO and renal injury.

Main Methods:

• A case-control study involving 25 children with UPJO and 25 matched healthy peers.
• Urine samples were collected to measure urinary TGF-β1 using ELISA.
• Renal function was assessed by glomerular filtration rate (GFR), and UPJO severity by ultrasonography.

Main Results:

• Children with UPJO exhibited significantly higher mean urinary TGF-β1 levels (87.1 pg/ml) compared to controls (30.5 pg/ml).
• Urinary TGF-β1 levels correlated with the degree of UPJO, with Grade IV hydronephrosis showing the highest levels (P = 0.0001).
• Mean GFR was slightly lower in the UPJO group (112.4) than in the control group (123.29).

Conclusions:

• Urinary TGF-β1 serves as a potential biomarker for confirming UPJO in pediatric cases.
• Further research is warranted to establish specific diagnostic cut-off points for TGF-β1 in UPJO.
• Biomarker analysis can aid in the non-invasive assessment of UPJO severity and potential renal impact.